Pancreatic Islet Function, Insulin Sensitivity, and Chronic Complications in Pre-Diabetes

The recruitment status of this study is unknown because the information has not been verified recently.
Verified April 2005 by National Taiwan University Hospital.
Recruitment status was  Recruiting
Sponsor:
Information provided by:
National Taiwan University Hospital
ClinicalTrials.gov Identifier:
NCT00172796
First received: September 12, 2005
Last updated: March 29, 2006
Last verified: April 2005
  Purpose

We, the investigators at National Taiwan University Hospital, want to compare patients' islet cell function, insulin sensitivity and risk of chronic complications with normal subjects. Moreover, we want to examine whether they are at a higher risk of having metabolic syndrome and to answer whether we should screen the phenotypes of metabolic syndrome in impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) patients. Then, we want to examine the association between insulin sensitivity and islet functions.


Condition
Prediabetic State
Obesity
Metabolic Syndrome X

Study Type: Observational
Study Design: Observational Model: Case Control
Time Perspective: Cross-Sectional

Resource links provided by NLM:


Further study details as provided by National Taiwan University Hospital:

Study Start Date: April 2005
Detailed Description:

We, the investigators at National Taiwan University Hospital, want to compare patients' islet cell function, insulin sensitivity and risk of chronic complications with normal subjects. Moreover, we want to examine whether they are at a higher risk of having metabolic syndrome and to answer whether we should screen the phenotypes of metabolic syndrome in impaired fasting glucose (IFG) and impaired glucose tolerance (IGT) patients. Then, we want to examine the association between insulin sensitivity and islet functions.

  Eligibility

Ages Eligible for Study:   18 Years and older
Genders Eligible for Study:   Both
Criteria

Inclusion Criteria:

  • Fasting glucose 100-125 mg/dl OR oral glucose tolerance test (OGTT) 2 hour glucose 140-199 mg/dl
  • Diabetes mellitus

Exclusion Criteria:

  • Pregnancy
  • Children < 18 years old
  Contacts and Locations
Choosing to participate in a study is an important personal decision. Talk with your doctor and family members or friends about deciding to join a study. To learn more about this study, you or your doctor may contact the study research staff using the Contacts provided below. For general information, see Learn About Clinical Studies.

Please refer to this study by its ClinicalTrials.gov identifier: NCT00172796

Locations
Taiwan
Department of Internal Medicine, Yun-Lin Branch, National Taiwan University Hospital Recruiting
Yun-Lin, Taiwan, 640
Contact: Hung-Yuan Li, MD    886-5-5323911      
Sponsors and Collaborators
National Taiwan University Hospital
Investigators
Principal Investigator: Hung-Yuan Li, MD Yun-Lin Branch, National Taiwan University Hospital
  More Information

No publications provided

ClinicalTrials.gov Identifier: NCT00172796     History of Changes
Other Study ID Numbers: 940202
Study First Received: September 12, 2005
Last Updated: March 29, 2006
Health Authority: Taiwan: Department of Health

Keywords provided by National Taiwan University Hospital:
Metabolic syndrome

Additional relevant MeSH terms:
Metabolic Syndrome X
Syndrome
Prediabetic State
Insulin Resistance
Hyperinsulinism
Glucose Metabolism Disorders
Metabolic Diseases
Disease
Pathologic Processes
Diabetes Mellitus
Endocrine System Diseases

ClinicalTrials.gov processed this record on September 22, 2014